<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">PRP </span>
   <span class="font28">PRPr </span>
   <span class="font19">(Fig. </span>
   <span class="font18"> °C </span>
   <span class="font18">angiogenesis </span>
   <span class="font17">plasma </span>
   <span class="font17">blood </span>
   <span class="font17">tissue </span>
   <span class="font17">growth </span>
   <span class="font17">wound </span>
   <span class="font16">induced </span>
   <span class="font16">platelet </span>
   <span class="font16">regenerative </span>
   <span class="font15">endothelial </span>
   <span class="font15">mediated </span>
   <span class="font15">obtained </span>
   <span class="font15">used </span>
   <span class="font15">vs. </span>
   <span class="font15">effect </span>
   <span class="font15">observed </span>
   <span class="font14">angiogenic </span>
   <span class="font14">regeneration </span>
   <span class="font14">using </span>
   <span class="font14">ASA </span>
   <span class="font14">diabetic </span>
   <span class="font14">incubated </span>
   <span class="font14">skin </span>
   <span class="font14">{border-style </span>
   <span class="font14"> °C, </span>
   <span class="font14">cryoprecipitate </span>
   <span class="font14">days </span>
   <span class="font14">determined </span>
   <span class="font14">factors </span>
   <span class="font14">healing </span>
   <span class="font14">px;} </span>
   <span class="font14">#ffffff;} </span>
   <span class="font14">O-PRPr </span>
   <span class="font14">proliferation </span>
   <span class="font13">analysed </span>
   <span class="font13">patients </span>
   <span class="font13">tubule </span>
   <span class="font13">healthy </span>
   <span class="font13">release </span>
   <span class="font13">wounds </span>
   <span class="font13">Fig. </span>
   <span class="font13">HMEC- </span>
   <span class="font13">associated </span>
   <span class="font13">formation </span>
   <span class="font13">platelets </span>
   <span class="font13"> ±  </span>
   <span class="font13">mice </span>
   <span class="font13">vitro </span>
   <span class="font12">compared </span>
   <span class="font12">human </span>
   <span class="font12">induce </span>
   <span class="font12">treatment </span>
   <span class="font12">cell </span>
   <span class="font12">cells </span>
   <span class="font12">following </span>
   <span class="font12">granulation </span>
   <span class="font12">migration, </span>
   <span class="font12">preparation </span>
   <span class="font12">significantly </span>
   <span class="font12">vivo </span>
   <span class="font12">IL-, </span>
   <span class="font12">ImageJ </span>
   <span class="font12">cold </span>
   <span class="font12">containing </span>
   <span class="font12">diluted </span>
   <span class="font12">higher </span>
   <span class="font12">migration </span>
   <span class="font12">optimisation </span>
   <span class="font12">proliferation, </span>
   <span class="font12">releasates </span>
   <span class="font12">supplemented </span>
   <span class="font12">activity </span>
   <span class="font12">addition </span>
   <span class="font12">annex </span>
   <span class="font12">area </span>
   <span class="font12">closure </span>
   <span class="font12">day </span>
   <span class="font12">development </span>
   <span class="font12">dilution </span>
   <span class="font12">factor </span>
   <span class="font12">findings </span>
   <span class="font12">including </span>
   <span class="font12">increased </span>
   <span class="font12">injection </span>
   <span class="font12">partially </span>
   <span class="font12">platelet-derived </span>
   <span class="font12">reduction </span>
   <span class="font12">responses </span>
   <span class="font12">temperature </span>
   <span class="font12">vessels </span>
   <span class="font12"> min, </span>
   <span class="font11">***P &amp;lt; . </span>
   <span class="font11">**P &amp;lt; ., </span>
   <span class="font11">EGF </span>
   <span class="font11">Figure </span>
   <span class="font11">PRPr. </span>
   <span class="font11">VEGF </span>
   <span class="font11">WPr </span>
   <span class="font11">chronic </span>
   <span class="font11">clinical </span>
   <span class="font11">coagulation </span>
   <span class="font11">levels </span>
   <span class="font11">molecules </span>
   <span class="font11">platelet-rich </span>
   <span class="font11">platelets. </span>
   <span class="font11">preconditioning </span>
   <span class="font11">presence </span>
   <span class="font11">px; </span>
   <span class="font11">samples </span>
   <span class="font11">software. </span>
   <span class="font11">structures </span>
   <span class="font11">{font-family </span>
   <span class="font11"> min. </span>
   <span class="font11">Angiogenesis </span>
   <span class="font11">B). </span>
   <span class="font11">CaCl </span>
   <span class="font11">PRP. </span>
   <span class="font11">Saline </span>
   <span class="font11">control </span>
   <span class="font11">control; </span>
   <span class="font11">derived </span>
   <span class="font11">font-size </span>
   <span class="font11">improve </span>
   <span class="font11">improved </span>
   <span class="font11">low </span>
   <span class="font11">new </span>
   <span class="font11">phenomenon </span>
   <span class="font11">properties </span>
   <span class="font11">secretion </span>
   <span class="font11">similar </span>
   <span class="font11"> min </span>
   <span class="font11">#P &amp;lt; ., </span>
   <span class="font11">(A) </span>
   <span class="font11">(B) </span>
   <span class="font11">(C) </span>
   <span class="font11">(Suppl. </span>
   <span class="font11">( mM) </span>
   <span class="font11">A). </span>
   <span class="font11">EGF, </span>
   <span class="font11">PRPr; </span>
   <span class="font11">VEGF, </span>
   <span class="font11">Wound </span>
   <span class="font11">ability </span>
   <span class="font11">angiogenesis, </span>
   <span class="font11">angiogenesis. </span>
   <span class="font11">complete </span>
   <span class="font11">concentration </span>
   <span class="font11">control. </span>
   <span class="font11">controlled </span>
   <span class="font11">current </span>
   <span class="font11">dilution, </span>
   <span class="font11">double; </span>
   <span class="font11">enhance </span>
   <span class="font11">epidermal </span>
   <span class="font11">experiments, </span>
   <span class="font11">generated </span>
   <span class="font11">immature </span>
   <span class="font11">increasing </span>
   <span class="font11">inhibited </span>
   <span class="font11">methods </span>
   <span class="font11">patients. </span>
   <span class="font11">previous </span>
   <span class="font11">previously </span>
   <span class="font11">pro-angiogenic </span>
   <span class="font11">protocols </span>
   <span class="font11">results </span>
   <span class="font11">reversed </span>
   <span class="font11">saline </span>
   <span class="font11">that, </span>
   <span class="font11">treated </span>
   <span class="font11">use </span>
   <span class="font11"> × g </span>
   <span class="font11">###P &amp;lt; . </span>
   <span class="font11">##P &amp;lt; ., </span>
   <span class="font11">( × ) </span>
   <span class="font11">ASA-treated </span>
   <span class="font11">Care </span>
   <span class="font11">Endothelial </span>
   <span class="font11">FBS </span>
   <span class="font11">Following </span>
   <span class="font11">Furthermore, </span>
   <span class="font11">Images </span>
   <span class="font11">Masson’s </span>
   <span class="font11">Moreover, </span>
   <span class="font11">Next, </span>
   <span class="font11">Plasma </span>
   <span class="font11">Remarkably, </span>
   <span class="font11">USA) </span>
   <span class="font11">USA), </span>
   <span class="font11">activation </span>
   <span class="font11">agreement </span>
   <span class="font11">alpha </span>
   <span class="font11">analysis </span>
   <span class="font11">anti-angiogenic </span>
   <span class="font11">bFGF, </span>
   <span class="font11">biopsies </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">centrifuged </span>
   <span class="font11">completely </span>
   <span class="font11">concentrations </span>
   <span class="font11">demonstrate </span>
   <span class="font11">dermal </span>
   <span class="font11">different </span>
   <span class="font11">diseases </span>
   <span class="font11">donors </span>
   <span class="font11">effects </span>
   <span class="font11">excisional </span>
   <span class="font11">expressed </span>
   <span class="font11">filters </span>
   <span class="font11">full-thickness </span>
   <span class="font11">granule </span>
   <span class="font11">improving </span>
   <span class="font11">inhibitory </span>
   <span class="font11">injected </span>
   <span class="font11">large </span>
   <span class="font11">maturation </span>
   <span class="font11">method </span>
   <span class="font11">mouse </span>
   <span class="font11">non-optimised </span>
   <span class="font11">number </span>
   <span class="font11">optimisation. </span>
   <span class="font11">optimised </span>
   <span class="font11">percentage </span>
   <span class="font11">preconditioning, </span>
   <span class="font11">proangiogenic </span>
   <span class="font11">process </span>
   <span class="font11">repair </span>
   <span class="font11">shown </span>
   <span class="font11">significant </span>
   <span class="font11">solid; </span>
   <span class="font11">stained </span>
   <span class="font11">standard </span>
   <span class="font11">study </span>
   <span class="font11">supplementation </span>
   <span class="font11">thickness </span>
   <span class="font11">triggered </span>
   <span class="font11">vessel </span>
   <span class="font11">volume </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11"> °C. </span>
   <span class="font10">*P &amp;lt; ., </span>
   <span class="font10">. ± . </span>
   <span class="font10">ASA. </span>
   <span class="font10">Commons </span>
   <span class="font10">Creative </span>
   <span class="font10">Experimental </span>
   <span class="font10">Growth </span>
   <span class="font10">However, </span>
   <span class="font10">J.E. </span>
   <span class="font10">Thus, </span>
   <span class="font10">absence </span>
   <span class="font10">addition, </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">anti-platelet </span>
   <span class="font10">assays </span>
   <span class="font10">autologous </span>
   <span class="font10">bold </span>
   <span class="font10">cardiovascular </span>
   <span class="font10">clotting </span>
   <span class="font10">combination </span>
   <span class="font10">complex </span>
   <span class="font10">considered </span>
   <span class="font10">contrast, </span>
   <span class="font10">courier; </span>
   <span class="font10">data </span>
   <span class="font10">data, </span>
   <span class="font10">described. </span>
   <span class="font10">drug </span>
   <span class="font10">em; </span>
   <span class="font10">enhanced </span>
   <span class="font10">factor; </span>
   <span class="font10">high </span>
   <span class="font10">improvement </span>
   <span class="font10">indicate </span>
   <span class="font10">indicating </span>
   <span class="font10">inhibition </span>
   <span class="font10">inverted </span>
   <span class="font10">involved </span>
   <span class="font10">local </span>
   <span class="font10">manuscript. </span>
   <span class="font10">material </span>
   <span class="font10">matrix </span>
   <span class="font10">methods. </span>
   <span class="font10">mice, </span>
   <span class="font10">perimeter </span>
   <span class="font10">periphery </span>
   <span class="font10">plasma, </span>
   <span class="font10">possible </span>
   <span class="font10">post-injury. </span>
   <span class="font10">pre-incubated </span>
   <span class="font10">pre-incubation </span>
   <span class="font10">protein </span>
   <span class="font10">protocol </span>
   <span class="font10">pt;} </span>
   <span class="font10">recombinant </span>
   <span class="font10">regarding </span>
   <span class="font10">requires </span>
   <span class="font10">role </span>
   <span class="font10">round </span>
   <span class="font10">sebaceous </span>
   <span class="font10">signalling </span>
   <span class="font10">software </span>
   <span class="font10">stored </span>
   <span class="font10">studies </span>
   <span class="font10">subcutaneously </span>
   <span class="font10">supplementation. </span>
   <span class="font10">therapy </span>
   <span class="font10">total </span>
   <span class="font10">treatments </span>
   <span class="font10">variables </span>
   <span class="font10">vascular </span>
   <span class="font10"> mm </span>
   <span class="font10"> °C; </span>
   <span class="font10">‡P &amp;lt; ., </span>
  </p>
 </body>
</html>
